174 related articles for article (PubMed ID: 34114220)
21. Immune-Mediated Thrombocytopenia Associated With Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine.
Banerjee S; Sandhu M; Tonzi E; Tambe A; Gambhir HS
Am J Ther; 2021 Aug; 28(5):e604-e606. PubMed ID: 34469919
[No Abstract] [Full Text] [Related]
22. Idiopathic Thrombocytopenic Purpura and the Moderna Covid-19 Vaccine.
Julian JA; Mathern DR; Fernando D
Ann Emerg Med; 2021 Jun; 77(6):654-656. PubMed ID: 34030782
[No Abstract] [Full Text] [Related]
23. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
[No Abstract] [Full Text] [Related]
24. Immune thrombocytopenia following SARS-CoV-2 vaccination in a female: Report of one case.
Lee ZM; Chen YC; Liu SC; Wang CC
Pediatr Blood Cancer; 2023 May; 70(5):e30211. PubMed ID: 36726145
[No Abstract] [Full Text] [Related]
25. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Sato K; Anayama M; Sumi M; Kobayashi H
Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
[TBL] [Abstract][Full Text] [Related]
26. Models for SARS-CoV-2 associated thrombocytopenia associated with hemophagocytic histiocytes.
Ricke DO
Med Hypotheses; 2021 Dec; 157():110700. PubMed ID: 34673371
[TBL] [Abstract][Full Text] [Related]
27. Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination.
Saito K; Ichikawa S; Hatta S; Katsuoka Y; Harigae H; Izumi T
Ann Hematol; 2022 Apr; 101(4):885-887. PubMed ID: 34599382
[No Abstract] [Full Text] [Related]
28. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
[TBL] [Abstract][Full Text] [Related]
30. Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine.
Krajewski PK; Szepietowski JC
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e626-e627. PubMed ID: 34077572
[No Abstract] [Full Text] [Related]
31. Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
Georgy JT; Jayakaran JAJ; Jacob AS; Gunasekaran K; Korula PJ; Devasia AJ; Iyadurai R
J Med Virol; 2021 May; 93(5):2642-2644. PubMed ID: 33634495
[No Abstract] [Full Text] [Related]
32. Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients.
García Ramírez P; Castilla García L; Aspa Cilleruelo JM
Med Clin (Barc); 2022 May; 158(10):497-498. PubMed ID: 34666903
[No Abstract] [Full Text] [Related]
33. Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
Pavord S; Hunt BJ; Horner D; Bewley S; Karpusheff J;
BMJ; 2021 Oct; 375():n2195. PubMed ID: 34598931
[No Abstract] [Full Text] [Related]
34. Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Capecchi M; De Leo P; Abbattista M; Mancini I; Agosti P; Biganzoli M; Suffritti C; Ferrari B; Lecchi A; La Marca S; Padovan L; Scalambrino E; Clerici M; Tripodi A; Artoni A; Gualtierotti R; Peyvandi F
Haematologica; 2023 Nov; 108(11):3152-3155. PubMed ID: 36951158
[No Abstract] [Full Text] [Related]
35. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
[No Abstract] [Full Text] [Related]
36. SARS-CoV-2 Infection in Patients with a History of VITT.
Schönborn L; Seck SE; Thiele T; Warkentin TE; Greinacher A
N Engl J Med; 2022 Jul; 387(1):88-90. PubMed ID: 35759529
[No Abstract] [Full Text] [Related]
37. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
38. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
Shah H; Kim A; Sukumar S; Mazepa M; Kohli R; Braunstein EM; Brodsky RA; Cataland S; Chaturvedi S
Blood; 2022 Apr; 139(16):2570-2573. PubMed ID: 35259252
[No Abstract] [Full Text] [Related]
40. SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia.
Hillier K; Rothman JA; Klaassen RJ; Neunert C; Rose MJ; Grace RF; Lambert MP
Pediatr Blood Cancer; 2022 Jul; 69(7):e29760. PubMed ID: 35561101
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
